Fabry Disease Patient Recruitment in Utah

TheraNovex connects clinical trial sponsors with pre-screened, eligible Fabry Disease patients across Utah, including Salt Lake City, West Valley City, Provo, and beyond.

Fabry disease patient recruitment for ERT, chaperone therapy, and substrate reduction clinical trials.

Who qualifies: Males and females with confirmed Fabry disease (GLA mutation) with or without prior ERT.

Recruitment challenges: GLA mutation confirmation and alpha-galactosidase A enzyme activity requirements.

Our approach: Metabolic disease center networks, Fabry patient registry access, and enzyme activity pre-screening.

Our recruitment network spans all major metropolitan areas in Utah, ensuring broad geographic coverage for your Fabry Disease trial.